An initiative focusing on reducing the use of supplier loan kits within orthopaedic theatres is having a positive impact financially, operationally and environmentally.

To help reduce the costs associated with specialist orthopaedic loan equipment, a multidisciplinary team recently organised a review of the 76 loan kits the department regularly used. The review was carried out collaboratively with clinicians, theatre teams, procurement and suppliers to identify opportunities to reduce duplication of items and lessen the need to rely on externally supplied loan kits.

This has resulted in only nine kits being agreed for routine availability through a new digital loan kit request process. Requests outside of those nine will still be possible where clinically required but will need a clear patient-specific rationale and additional approval.

The impact of this project has meant that £12,000 worth of savings have been made since 1 April 2026. It is expected that a further £72,000 will be made by 31 March 2027 and based on the work done so far, the anticipated savings for next year are anticipated to be around £120,000.

Matron, Sarah Wallwork, said: "For the Trust, it gives us better governance, clearer clinical ownership and much greater control over expenditure.

“For patients and theatre teams, it should also mean that equipment we genuinely use regularly is available through more reliable and sustainable arrangements, while retaining access to specialist equipment when there is a clear clinical need."

Assistant Category Manager, Nick Knopwood, said: "By reducing reliance on loan kits and ensuring equipment is available when and where it is needed, CHFT has delivered a project that not only contributes to CIP savings but also improves theatre efficiency, enhances patient experience, reduces environmental impact and supports the delivery of sustainable healthcare services."